Alnylam Pharma(CH:DUL)
CHF 138.580.00 (0.00%)
CH:DUL
Alnylam Pharma ownership
CHF 138.58
At close:0.00 (0.00%)
Alnylam Pharma (DUL) Ownership - Who Owns Alnylam Pharma?
0 Followers
Alnylam Pharma (DUL) Ownership Overview
- 0.24% Insiders
- 44.45% Mutual Funds
- 6.23% Other Institutional Investors
- 25.09% ETFs
- 23.98% Public Companies and Individual Investors
The ownership structure of Alnylam Pharma (CH:DUL) stock is a mix of institutional, retail, and individual investors. Approximately 75.78% of the company’s stock is owned by Institutional Investors, 0.24% is owned by Insiders, and 23.98% is owned by Public Companies and Individual Investors.
The ownership structure of Alnylam Pharma (CH:DUL) stock is a mix of institutional, retail, and individual investors. Approximately 75.78% of the company’s stock is owned by Institutional Investors, 0.24% is owned by Insiders, and 23.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 06, 2026 | Melissa Mclaughlin | $519,014 | |
| Mar 05, 2026 | Pushkal Garg | $745,984 | |
| Mar 05, 2026 | Yvonne Greenstreet | $947,581 | |
| Mar 05, 2026 | Jeffrey V. Poulton | $797,351 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | CHF233,818 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | CHF607,211 | |
| Dec 31, 2025 | Woodline Partners Lp | CHF699,466 | |
| Dec 31, 2025 | Sivik Global Healthcare Llc | CHF1,192,950 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 12,683,296 | Institution | 9.47% | 2,111,908,300 |
| Vanguard Index Funds | 11,465,798 | Institution | 8.56% | 1,909,181,491 |
| BlackRock, Inc. | 10,907,675 | Institution | 8.14% | 1,816,247,872 |
| Growth Fund Of America | 8,960,487 | Institution | 6.69% | 1,492,019,651 |
| Ishares | 6,710,304 | Institution | 5.01% | 1,117,339,429 |
| Amcap Fund | 4,526,680 | Institution | 3.38% | 753,742,013 |
| Invesco | 4,361,695 | Institution | 3.26% | 726,270,196 |
| Fidelity Securities Fund | 2,942,338 | Institution | 2.20% | 489,931,643 |
| Amundi | 2,687,501 | Institution | 2.01% | 447,498,479 |
| Vanguard Specialized Funds | 2,136,580 | Institution | 1.60% | 355,764,072 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 11,465,798 | Institution | 8.56% | 1,909,181,491 |
| Growth Fund Of America | 8,960,487 | Institution | 6.69% | 1,492,019,651 |
| Amcap Fund | 4,526,680 | Institution | 3.38% | 753,742,013 |
| Fidelity Securities Fund | 2,942,338 | Institution | 2.20% | 489,931,643 |
| Vanguard Specialized Funds | 2,136,580 | Institution | 1.60% | 355,764,072 |
| T. Rowe Price Capital Appreciation Fund, Inc. | 2,034,761 | Institution | 1.52% | 338,810,089 |
| Investment Co Of America | 1,612,942 | Institution | 1.20% | 268,572,585 |
| Dodge & Cox Funds | 1,448,441 | Institution | 1.08% | 241,181,359 |
| Fidelity Mt. Vernon Street Trust | 1,403,578 | Institution | 1.05% | 233,711,176 |
| Fidelity Concord Street Trust | 1,377,518 | Institution | 1.03% | 229,371,900 |
FAQ
Who Owns Alnylam Pharma (CH:DUL)?
According to the latest TipRanks data, approximately 75.78% of the company's stock is held by institutional investors, 0.24% is held by insiders, and 23.98% is held by public companies and individual investors.
What percentage of Alnylam Pharma (CH:DUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 75.78% of Alnylam Pharma (CH:DUL) stock is held by institutional investors: 44.45% by mutual funds, 25.09% by ETFs and 6.23% by other institutional investors.
What percentage of Alnylam Pharma (CH:DUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.98% of Alnylam Pharma (CH:DUL) stock is held by public companies and individual investors.
Who owns the most shares of Alnylam Pharma (CH:DUL)?
Vanguard owns the most shares of Alnylam Pharma (CH:DUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
